TR8™: the New Enabling Technology for Gene Editing
Transcending Obstacles of Gene Editing
GeneNeer’s TR8™ Regulation Platform facilitates more accurate, faster, cheaper and safer gene editing than ever before. In some instances, the technology enables gene editing in crops that were difficult or simply impossible to modify. With the TR8™ platform, crop seed development and regulatory approvals take less time, while the costs and risks for enhanced crop development are reduced.
Removal of the Gene Editing “Machinery”
One of the most significant benefits of the TR8™ Regulation Platform is its ability to control and extract the CRISPR Cas machinery during and following the gene editing process. This previously elusive capability is noteworthy, as it eliminates the remote possibility of unintentional secondary gene modification.
Here are a few additional challenges overcome by TR8™:
- Creating hybrids due to cross incompatibility
- Obtaining quality protoplast transformation assay
- Modifying a Large genome (hexaploidy)
Using its proprietary TR8™ Regulation Platform, GeneNeer is currently conducting research on potatoes and sweet potatoes to facilitate and enable, respectively, gene editing that will enhance crop tolerance, nutrition and cooking properties. In addition to achieving the desired performance, the goal is to reduce the time involved in conducting the gene editing process.
The TR8™ platform may be used in cooperation with other research and development methodologies, providing universal benefit to the gene-editing industry!
Science In Pursuit Of Food Security
Using its proprietary TR8™ Regulation Platform, GeneNeer is currently conducting research on potatoes and sweet potatoes to facilitate and enable, respectively, gene editing that will enhance crop tolerance, nutrition and cooking properties. In addition to achieving the desired performance, the goal is to reduce the time involved in conducting the gene editing process.
The TR8™ platform may be used in cooperation with other research and development methodologies, providing universal benefit to the gene-editing industry!
